255 related articles for article (PubMed ID: 28724435)
21. Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway.
Webb C; Upadhyay A; Giuntini F; Eggleston I; Furutani-Seiki M; Ishima R; Bagby S
Biochemistry; 2011 Apr; 50(16):3300-9. PubMed ID: 21417403
[TBL] [Abstract][Full Text] [Related]
22. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
23. Functions and Epigenetic Regulation of Wwox in Bone Metastasis from Breast Carcinoma: Comparison with Primary Tumors.
Maroni P; Matteucci E; Bendinelli P; Desiderio MA
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28045433
[TBL] [Abstract][Full Text] [Related]
24. Physical and functional interactions between the transactivation domain of the hematopoietic transcription factor NF-E2 and WW domains.
Mosser EA; Kasanov JD; Forsberg EC; Kay BK; Ney PA; Bresnick EH
Biochemistry; 1998 Sep; 37(39):13686-95. PubMed ID: 9753456
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal Regulation of Hippo and WBP2 Signalling-Implications in Cancer Therapy.
Lim YX; Lin H; Seah SH; Lim YP
Cells; 2021 Nov; 10(11):. PubMed ID: 34831354
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.
Li YW; Guo J; Shen H; Li J; Yang N; Frangou C; Wilson KE; Zhang Y; Mussell AL; Sudol M; Farooq A; Qu J; Zhang J
Cell Cycle; 2016 Sep; 15(18):2497-505. PubMed ID: 27428284
[TBL] [Abstract][Full Text] [Related]
27. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function.
Aqeilan RI; Donati V; Palamarchuk A; Trapasso F; Kaou M; Pekarsky Y; Sudol M; Croce CM
Cancer Res; 2005 Aug; 65(15):6764-72. PubMed ID: 16061658
[TBL] [Abstract][Full Text] [Related]
28. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.
Aqeilan RI; Palamarchuk A; Weigel RJ; Herrero JJ; Pekarsky Y; Croce CM
Cancer Res; 2004 Nov; 64(22):8256-61. PubMed ID: 15548692
[TBL] [Abstract][Full Text] [Related]
29. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
Chang NS; Schultz L; Hsu LJ; Lewis J; Su M; Sze CI
Oncogene; 2005 Jan; 24(4):714-23. PubMed ID: 15580310
[TBL] [Abstract][Full Text] [Related]
30. WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins.
Ludes-Meyers JH; Kil H; Bednarek AK; Drake J; Bedford MT; Aldaz CM
Oncogene; 2004 Jun; 23(29):5049-55. PubMed ID: 15064722
[TBL] [Abstract][Full Text] [Related]
31. Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors.
Matteucci E; Maroni P; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
Eur J Cancer; 2013 Jan; 49(1):231-44. PubMed ID: 22717556
[TBL] [Abstract][Full Text] [Related]
32. Biophysical studies and modelling indicate the binding preference of TAZ WW domain for LATS1 PPxY motif.
Verma A; Lin F; Tan YC; Hidayat MN; Jobichen C; Fan H; Sivaraman J
Biochem Biophys Res Commun; 2018 Jul; 502(3):307-312. PubMed ID: 29787761
[TBL] [Abstract][Full Text] [Related]
33. WBP-2, a WW domain binding protein, interacts with the thyroid-specific transcription factor Pax8.
Nitsch R; Di Palma T; Mascia A; Zannini M
Biochem J; 2004 Feb; 377(Pt 3):553-60. PubMed ID: 14531730
[TBL] [Abstract][Full Text] [Related]
34. Wbp2 is required for normal glutamatergic synapses in the cochlea and is crucial for hearing.
Buniello A; Ingham NJ; Lewis MA; Huma AC; Martinez-Vega R; Varela-Nieto I; Vizcay-Barrena G; Fleck RA; Houston O; Bardhan T; Johnson SL; White JK; Yuan H; Marcotti W; Steel KP
EMBO Mol Med; 2016 Mar; 8(3):191-207. PubMed ID: 26881968
[TBL] [Abstract][Full Text] [Related]
35. RHBDD2‑WWOX protein interaction during proliferative and differentiated stages in normal and breast cancer cells.
Ferretti VA; Canzoneri R; Palma S; Lacunza E; Aldaz CM; Abba MC
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109992
[TBL] [Abstract][Full Text] [Related]
36. Cancerous Protein Network That Inhibits the Tumor Suppressor Function of WW Domain-Containing Oxidoreductase (WWOX) by Aberrantly Expressed Molecules.
Saigo C; Kito Y; Takeuchi T
Front Oncol; 2018; 8():350. PubMed ID: 30214895
[TBL] [Abstract][Full Text] [Related]
37. WW domain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors.
Dhananjayan SC; Ramamoorthy S; Khan OY; Ismail A; Sun J; Slingerland J; O'Malley BW; Nawaz Z
Mol Endocrinol; 2006 Oct; 20(10):2343-54. PubMed ID: 16772533
[TBL] [Abstract][Full Text] [Related]
38. Structural insights into the role of the WW2 domain on tandem WW-PPxY motif interactions of oxidoreductase WWOX.
Rotem-Bamberger S; Fahoum J; Keinan-Adamsky K; Tsaban T; Avraham O; Shalev DE; Chill JH; Schueler-Furman O
J Biol Chem; 2022 Aug; 298(8):102145. PubMed ID: 35716775
[TBL] [Abstract][Full Text] [Related]
39. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.
Mahajan NP; Whang YE; Mohler JL; Earp HS
Cancer Res; 2005 Nov; 65(22):10514-23. PubMed ID: 16288044
[TBL] [Abstract][Full Text] [Related]
40. Association of Wwox with ErbB4 in breast cancer.
Aqeilan RI; Donati V; Gaudio E; Nicoloso MS; Sundvall M; Korhonen A; Lundin J; Isola J; Sudol M; Joensuu H; Croce CM; Elenius K
Cancer Res; 2007 Oct; 67(19):9330-6. PubMed ID: 17909041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
